CLINICAL_TRIALS
trial_result
· 2025-02-20
Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo [Phase 2]
Summary
Phase 2 study evaluating the safety and efficacy of Ruxolitinib Cream with phototherapy in vitiligo; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Vitiligo | Phase 2 | Status: COMPLETED | Results posted: 2025-02-20